Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 109 items for :

Clear All
Emmanuel K Fai University of Maryland Medical Center Midtown Campus, Baltimore, Maryland, USA

Search for other papers by Emmanuel K Fai in
Google Scholar
PubMed Close
,
Cheryl Anderson Walden University, Minneapolis, Minnesota, USA

Search for other papers by Cheryl Anderson in
Google Scholar
PubMed Close
, and
Victor Ferreros Walden University, Minneapolis, Minnesota, USA

Search for other papers by Victor Ferreros in
Google Scholar
PubMed Close

Introduction Individual patient attitudes and intentions can influence adherence to the use of medical therapies. ‘Adherence to the use of medical therapy’ has been defined as the level of participation expected of an individual who has agreed

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0093
Volume/Issue:
Volume 6: Issue 2
Open access
Ekaterina Koledova Biopharma Global Medical Affairs, General Medicine and Endocrinology, Merck KGaA, Darmstadt, Germany

Search for other papers by Ekaterina Koledova in
Google Scholar
PubMed Close
,
George Stoyanov Biopharma Global Medical Affairs, General Medicine and Endocrinology, Merck KGaA, Darmstadt, Germany

Search for other papers by George Stoyanov in
Google Scholar
PubMed Close
,
Leroy Ovbude Business & Decision Life Sciences, Brussels, Woluwe-Saint-Lambert, Belgium

Search for other papers by Leroy Ovbude in
Google Scholar
PubMed Close
, and
Peter S W Davies Children’s Nutrition Research Centre, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia

Search for other papers by Peter S W Davies in
Google Scholar
PubMed Close

, and daily subcutaneous injections may present a significant burden ( 6 ). Poor adherence to the injection regimen is a major concern in the management of growth disorders, and regular assessment of adherence is an essential component of successful

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0172
Volume/Issue:
Volume 7: Issue 8
Open access
María Dolores Rodríguez Arnao Pediatric Endocrinology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other papers by María Dolores Rodríguez Arnao in
Google Scholar
PubMed Close
,
Amparo Rodríguez Sánchez Pediatric Endocrinology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other papers by Amparo Rodríguez Sánchez in
Google Scholar
PubMed Close
,
Ignacio Díez López Hospital Universitario Araba, Araba/Alava, Spain

Search for other papers by Ignacio Díez López in
Google Scholar
PubMed Close
,
Joaquín Ramírez Fernández Hospital Universitario Príncipe de Asturias, Oviedo, Spain

Search for other papers by Joaquín Ramírez Fernández in
Google Scholar
PubMed Close
,
Jose Antonio Bermúdez de la Vega Centro Nuevas Tecnologias, Sevilla, Spain

Search for other papers by Jose Antonio Bermúdez de la Vega in
Google Scholar
PubMed Close
,
Diego Yeste Fernández Hospital Vall d’Hebrón, Barcelona, Spain

Search for other papers by Diego Yeste Fernández in
Google Scholar
PubMed Close
,
María Chueca Guindulain Complejo Hospitalario de Navarra, Pamplona, Spain

Search for other papers by María Chueca Guindulain in
Google Scholar
PubMed Close
,
Raquel Corripio Collado Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain

Search for other papers by Raquel Corripio Collado in
Google Scholar
PubMed Close
,
Jacobo Pérez Sánchez Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain

Search for other papers by Jacobo Pérez Sánchez in
Google Scholar
PubMed Close
,
Ana Fernández González Merck S.L.U., Madrid, Spain

Search for other papers by Ana Fernández González in
Google Scholar
PubMed Close
, and
ECOS Spain Study Collaborative Investigator Group
Search for other papers by ECOS Spain Study Collaborative Investigator Group in
Google Scholar
PubMed Close

periods of time ( 7 ). Some studies have suggested that non-adherence to treatment occurs in a variable percentage of subjects ( 8 , 9 , 10 ). The main cause for minor efficacy in r-hGH therapy is the lack of adherence to treatment or non

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0325
Volume/Issue:
Volume 8: Issue 9
Open access
Suma Uday Department of Endocrinology and Diabetes, Birmingham Children’s Hospital, Birmingham, UK

Search for other papers by Suma Uday in
Google Scholar
PubMed Close
,
Ardita Kongjonaj MEAL Specialist at Save the Children International, Albania Country Office, Tirana, Albania

Search for other papers by Ardita Kongjonaj in
Google Scholar
PubMed Close
,
Magda Aguiar Health Economics Unit, University of Birmingham, Birmingham, UK

Search for other papers by Magda Aguiar in
Google Scholar
PubMed Close
,
Ted Tulchinsky Braun School of Public Health and Community Medicine, and Ashkelon College, Ashkelon, Israel

Search for other papers by Ted Tulchinsky in
Google Scholar
PubMed Close
, and
Wolfgang Högler Department of Endocrinology and Diabetes, Birmingham Children’s Hospital, Birmingham, UK
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK

Search for other papers by Wolfgang Högler in
Google Scholar
PubMed Close

supplementation policies across Europe even for the existing population. We aimed to explore the differences in vitamin D policies and the factors relating to policy implementation that influence adherence rates. Methods A questionnaire with 20 questions

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0193
Volume/Issue:
Volume 6: Issue 8
Open access
Riccardo Pofi Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism and NIHR Oxford Biomedical Research Centre, Churchill Hospital, University of Oxford, Oxford, UK

Search for other papers by Riccardo Pofi in
Google Scholar
PubMed Close
,
Ilaria Bonaventura Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena, Rome, Italy

Search for other papers by Ilaria Bonaventura in
Google Scholar
PubMed Close
,
Joanne Duffy Department of Clinical Chemistry and Immunology, Heartlands Hospital, Birmingham, UK

Search for other papers by Joanne Duffy in
Google Scholar
PubMed Close
,
Zoe Maunsell Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Search for other papers by Zoe Maunsell in
Google Scholar
PubMed Close
,
Brian Shine Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Search for other papers by Brian Shine in
Google Scholar
PubMed Close
,
Andrea M Isidori Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena, Rome, Italy

Search for other papers by Andrea M Isidori in
Google Scholar
PubMed Close
, and
Jeremy W Tomlinson Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism and NIHR Oxford Biomedical Research Centre, Churchill Hospital, University of Oxford, Oxford, UK

Search for other papers by Jeremy W Tomlinson in
Google Scholar
PubMed Close

assessment of treatment adherence, an important factor that is also frequently neglected in randomized controlled trials ( 28 , 29 ). As a result, there is still a significant unmet clinical need to develop strategies that are able to facilitate the accurate

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-23-0059
Volume/Issue:
Volume 12: Issue 9
Open access
Régis Coutant Department of Pediatric Endocrinology and Diabetology, Reference Center for Rare Pituiatry Diseases, University Hospital of Angers, Angers, France

Search for other papers by Régis Coutant in
Google Scholar
PubMed Close
,
Maithé Tauber Reference Center for the Prader-Willi syndrome and other rare obesities with feeding disorders (PRADORT), Children Hospital, CHU Toulouse, Toulouse, France
Pediatric team of the Clinical Investigation Center 9302/INSERM, Hospital of Children, Toulouse, France
Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France

Search for other papers by Maithé Tauber in
Google Scholar
PubMed Close
,
Béatrice Demaret GRANDIR - French Growth Disorders Association, Asnières-sur-Seine, France

Search for other papers by Béatrice Demaret in
Google Scholar
PubMed Close
,
Robin Henocque Pfizer France, Paris France

Search for other papers by Robin Henocque in
Google Scholar
PubMed Close
,
Yves Brault Pfizer France, Paris France

Search for other papers by Yves Brault in
Google Scholar
PubMed Close
,
François Montestruc eXYSTAT, Malakoff, France

Search for other papers by François Montestruc in
Google Scholar
PubMed Close
,
Olivier Chassany Health Economics Clinical Trial Unit (URC-ECO), Hospital of Hotel-Dieu, AP-HP, Paris, France
Patient-Reported Outcomes Unit (PROQOL), UMR 1123, University Paris Cité, INSERM, Paris, France

Search for other papers by Olivier Chassany in
Google Scholar
PubMed Close
,
Michel Polak Hôpital Universitaire Necker Enfants Malades, Pediatric Endocrinology, Gynecology and Diabetology, Imagine Institute, INSERM U1163, Cochin Institute, INSERM U1016, Centre de référence des pathologies endocriniennes rares de la croissance et du développement, Université de Paris Cité, Paris, France

Search for other papers by Michel Polak in
Google Scholar
PubMed Close
, and
the QOLITHOR Study Group
Search for other papers by the QOLITHOR Study Group in
Google Scholar
PubMed Close
the QOLITHOR Study Group

improvement of psychosocial problems ( 3 , 4 ) and improvement in quality of life (QOL) ( 5 , 6 ). In addition, rhGH injections are well tolerated ( 7 , 8 ) even if adherence to treatment was shown as suboptimal ( 9 ). The majority of currently available

Article Type:
Research Article
Collections:
Paediatric Endocrinology
DOI:
https://doi.org/10.1530/EC-22-0464
Volume/Issue:
Volume 12: Issue 4
Open access
Shota Dzemaili University of Lausanne, Institute of Higher Education and Research in Healthcare, Lausanne, Switzerland

Search for other papers by Shota Dzemaili in
Google Scholar
PubMed Close
,
Jitske Tiemensma University of California Merced, Psychological Science, Merced, CA, USA

Search for other papers by Jitske Tiemensma in
Google Scholar
PubMed Close
,
Richard Quinton Department of Endocrinology, Institute for Human Genetics, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, United Kingdom

Search for other papers by Richard Quinton in
Google Scholar
PubMed Close
,
Nelly Pitteloud Endocrinology, Diabetes & Metabolism Service of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Search for other papers by Nelly Pitteloud in
Google Scholar
PubMed Close
,
Diane Morin University of Lausanne, Institute of Higher Education and Research in Healthcare, Lausanne, Switzerland
Faculty of Nursing Science, Laval University, Québec City, Canada

Search for other papers by Diane Morin in
Google Scholar
PubMed Close
, and
Andrew A Dwyer University of Lausanne, Institute of Higher Education and Research in Healthcare, Lausanne, Switzerland
Endocrinology, Diabetes & Metabolism Service of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Search for other papers by Andrew A Dwyer in
Google Scholar
PubMed Close

comparison with particular patient populations of interest (i.e. women with infertility and men with CHH and patients with rare endocrine disorders and chronic conditions). The Morisky Medication Adherence Scale (MMAS) is an 8-item instrument that assesses

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0095
Volume/Issue:
Volume 6: Issue 6
Open access
Shanhong Li Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China

Search for other papers by Shanhong Li in
Google Scholar
PubMed Close
,
Jincheng Tao Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China
Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China

Search for other papers by Jincheng Tao in
Google Scholar
PubMed Close
,
Jie Tang Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China

Search for other papers by Jie Tang in
Google Scholar
PubMed Close
,
Yanting Chu Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China

Search for other papers by Yanting Chu in
Google Scholar
PubMed Close
, and
Huiqun Wu Department of Medical Informatics, Medical School of Nantong University, Nantong, Jiangsu Province, China

Search for other papers by Huiqun Wu in
Google Scholar
PubMed Close

management warrant careful scrutiny. Conventional DM therapies face challenges, including enhancing medication adherence and improving patient prognosis, which necessitate resolution. Poor adherence to medication for primary chronic diseases can lead to

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-24-0219
Volume/Issue:
Volume 13: Issue 9
Open access
Jean-Philippe Bertocchio Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France
Centre de Référence des Maladies Rares du Calcium et du Phosphore Filière de Santé Maladies Rares OSCAR, Paris, France
Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, INSERM, UMRS1138, Paris, France

Search for other papers by Jean-Philippe Bertocchio in
Google Scholar
PubMed Close
,
Natalie Grosset Hypoparathyroïdisme France, Annecy, France

Search for other papers by Natalie Grosset in
Google Scholar
PubMed Close
,
Lionel Groussin Department of Endocrinology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Université de Paris, Paris, France

Search for other papers by Lionel Groussin in
Google Scholar
PubMed Close
,
Peter Kamenický Université Paris-Saclay, Inserm U1185, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphate, Le Kremlin-Bicêtre, France

Search for other papers by Peter Kamenický in
Google Scholar
PubMed Close
,
Fabrice Larceneux Université Paris-Dauphine, PSL Research University, CNRS, UMR 7088, DRM [Ermes], Paris, France

Search for other papers by Fabrice Larceneux in
Google Scholar
PubMed Close
,
Anne Lienhardt-Roussie CHU Dupuytren, Hôpital Mère Enfant, Endocrinologie Pédiatrique, Limoges, France

Search for other papers by Anne Lienhardt-Roussie in
Google Scholar
PubMed Close
,
Agnès Linglart Centre de Référence des Maladies Rares du Calcium et du Phosphore Filière de Santé Maladies Rares OSCAR, Paris, France
Université Paris-Saclay, Inserm U1185, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Service d’Endocrinologie et Diabète de l’Enfant, Centre de Référence des Maladies Rares du Calcium et du Phosphore et Filière de Santé Maladies Rares OSCAR, Hôpital Bicêtre Paris Saclay, Le Kremlin-Bicêtre, France

Search for other papers by Agnès Linglart in
Google Scholar
PubMed Close
,
Gérard Maruani Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France
Centre de Référence des Maladies Rares du Calcium et du Phosphore Filière de Santé Maladies Rares OSCAR, Paris, France
Assistance Publique-Hôpitaux de Paris, Institut Necker-Enfants Malades, INSERM U1151 – CNRS UMR 8253, Paris, France

Search for other papers by Gérard Maruani in
Google Scholar
PubMed Close
,
Eric Mirallie Chirurgie Cancérologique, Digestive et Endocrine, Institut des Maladies de l’Appareil Digestif, Hôtel Dieu, CHU Nantes, France
Association Francophone de Chirurgie Endocrinienne (AFCE), France

Search for other papers by Eric Mirallie in
Google Scholar
PubMed Close
,
François Pattou Université de Lille, CHU Lille, Institut Pasteur Lille, Inserm U1190, Lille, France

Search for other papers by François Pattou in
Google Scholar
PubMed Close
,
Riyad N H Seervai Molecular & Cellular Biology Graduate Program, Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA

Search for other papers by Riyad N H Seervai in
Google Scholar
PubMed Close
,
Coralie Sido Hypoparathyroïdisme France, Annecy, France

Search for other papers by Coralie Sido in
Google Scholar
PubMed Close
,
Caroline Silve Centre de Référence des Maladies Rares du Calcium et du Phosphore Filière de Santé Maladies Rares OSCAR, Paris, France
Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Biochimie et Génétique Moléculaires, Paris, France
INSERM, U1169, Université Paris Sud, Hôpital Bicêtre, Le Kremlin Bicêtre, France

Search for other papers by Caroline Silve in
Google Scholar
PubMed Close
,
Aurélie Vilfaillot Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Unité de Recherche Clinique, Paris, France
INSERM, U1418, CIC-EC, Hôpital Européen Georges Pompidou, Paris, France

Search for other papers by Aurélie Vilfaillot in
Google Scholar
PubMed Close
,
Antoine Tabarin Service Endocrinologie Diabète et Nutrition, CHU de Bordeaux, Université de Bordeaux, Pessac, France

Search for other papers by Antoine Tabarin in
Google Scholar
PubMed Close
,
Marie-Christine Vantyghem CHU Lille, Department of Endocrinology, Diabetology and Metabolism, Inserm U1190, EGID, Lille, France

Search for other papers by Marie-Christine Vantyghem in
Google Scholar
PubMed Close
,
Pascal Houillier Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France
Centre de Référence des Maladies Rares du Calcium et du Phosphore Filière de Santé Maladies Rares OSCAR, Paris, France
Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, INSERM, UMRS1138, Paris, France
CNRS, ERL8228, Paris, France

Search for other papers by Pascal Houillier in
Google Scholar
PubMed Close
, and
the investigators of the Épi-Hypo study
Search for other papers by the investigators of the Épi-Hypo study in
Google Scholar
PubMed Close
the investigators of the Épi-Hypo study

of Ca salt and active vitamin D could be related either to milder cases or to lower adherence to guidelines. Depending on the criteria, the adherence to international guidelines ( 4 , 5 , 7 ) could be graded differently: ‘high’ if we were to

Article Type:
Research Article
Collections:
Bone and Mineral Metabolism
DOI:
https://doi.org/10.1530/EC-21-0350
Volume/Issue:
Volume 11: Issue 1
Open access
Werner F Blum University Children’s Hospital, Giessen, Germany

Search for other papers by Werner F Blum in
Google Scholar
PubMed Close
,
Abdullah Alherbish Al Habib Medical Group, Riyadh, Saudi Arabia

Search for other papers by Abdullah Alherbish in
Google Scholar
PubMed Close
,
Afaf Alsagheir King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Search for other papers by Afaf Alsagheir in
Google Scholar
PubMed Close
,
Ahmed El Awwa Department of Pediatric Endocrinology & Diabetes, Hamad Medical Center, Doha, Qatar

Search for other papers by Ahmed El Awwa in
Google Scholar
PubMed Close
,
Walid Kaplan Tawam Hospital, Al Ain, UAE

Search for other papers by Walid Kaplan in
Google Scholar
PubMed Close
,
Ekaterina Koledova Global Medical Affairs Endocrinology, Merck KGaA, Darmstadt, Germany

Search for other papers by Ekaterina Koledova in
Google Scholar
PubMed Close
, and
Martin O Savage William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, UK

Search for other papers by Martin O Savage in
Google Scholar
PubMed Close

provocative testing. IGF-I and IGFBP-3 measurements can inform the clinician about adherence to GH treatment and, if maintained at <+2 SDS, will generally avoid GH over-dosage. As explained above, multiple factors can influence serum IGF-I and IGFBP-3

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-18-0099
Volume/Issue:
Volume 7: Issue 6
Open access